Lithuanian Echocardiography Study of Dyspnea in Acute Settings

CompletedOBSERVATIONAL
Enrollment

1,566

Participants

Timeline

Start Date

April 30, 2015

Primary Completion Date

December 31, 2017

Study Completion Date

November 30, 2018

Conditions
Acute Heart Failure
Interventions
PROCEDURE

Blood sampling

Besides routine clinical, laboratory and instrumental evaluation, blood samples will be taken within 4 hours of presentation to the hospital. Plasma samples, stored and frozen at -80°C, will be analyzed at the INSERM UMR942 institute in Paris. Up to 15 novel will be measured during the study: copeptine, proenkephalin, high sensitivity troponin T, troponin I, brain natriuretic peptide (BNP), N-terminal pro-BNP, adrenomedullin, soluble ST2, galectine 3, C-reactive protein, interleukine 6, procalcitonin, cystatin C, neutrophil gelatinase associated lipocalin.

PROCEDURE

Echocardiography exam

A standard echocardiography as well as examination focused on right ventricle (RV) will be performed in a period of 48 hours of admission. Novel qualitative and quantitative parameters of right ventricle function and structure will be measured. These include RV diameter at base and midlevel, a measure of RV fractional area change (FAC), tissue doppler imaging derived tricuspid lateral annular systolic velocity wave (S'), tricuspid annular plane systolic excursion (TAPSE), velocity and gradient of tricuspid regurgitation, estimated systolic RV and RA pressure, RV wall strain and strain rate.

Trial Locations (3)

50009

Lithuanian University of Health Sciences, Kaunas

75475

Inserm U942, Paris

08406

Vilnius University, Vilnius

All Listed Sponsors
collaborator

Institut National de la Santé Et de la Recherche Médicale, France

OTHER_GOV

collaborator

Lithuanian University of Health Sciences

OTHER

lead

Vilnius University

OTHER

NCT03048032 - Lithuanian Echocardiography Study of Dyspnea in Acute Settings | Biotech Hunter | Biotech Hunter